CROI 2016 Program at a Glance

Keyword Index

Mycobacterium tuberculosis - 157, 737 Myocardial infarction - 42, 641, 661, 662, 671 –N– NAFLD - 124, 553 Naive CD4T cell - 377 Naive patients - 437LB, 461LB, 486, 946 Nasopharynx-associated LymphoidTissue - 344 Natural history and recovery - 855 Natural Killer cells (NK) - 178, 179, 180, 315, 355 NCDs - 703 Needle-free technology - 323 Needle-sharing - 916 Nef - 57, 58, 136, 181, 190, 191, 253, 373 Neisseria gonorrhoeae - 1004, 1006 NeuroAIDS - 60, 61, 385, 423LB Neurocognition - 381, 416, 423LB Neurocognitive - 148, 175, 415 • Disorders - 63, 812 • Functioning - 386, 410, 418, 761 • Impairment - 145 • Performance - 147, 387 • Safety - 424LB Neuroimaging - 148, 381, 382, 383, 390, 423LB, 823 Neuroinflammation - 391, 397, 407, 411, 413, 414 Neurologic - 415 Neuromotor dysfunction - 415, 820 Neuronal injury - 395 Neuropath - 402 Neuropathogenesis - 394, 396, 405, 413 Neuropsychological impairment - 401 Neurosyphilis - 767 Neurotoxicity - 63, 394, 395, 397 Neutralization escape – 306, 309LB Neutralizing antibodies - 7, 88, 92, 301, 304, 307, 310LB, 400 Neutropenia - 962 Next Generation Sequencing (NGS) - 192, 210, 213, 232, 260, 325, 399, 487, 490, 539LB, 602 NF-kappaB - 463 NHBS - 906, 933 NNRTIs - 418 Non liver-related death - 612 Non-AIDS malignancy - 160, 616, 633 Non-AIDS mortality - 616, 710 Non-B subtype - 485 Non-communicable diseases - 676, 678, 679 Nevirapine - 444, 777, 815, 847 New oral HCV drugs - 66, 525

Non-Hodgkin lymphoma - 630 Nonhuman primate models – 20, 24, 107, 258LB, 263, 333, 447 Nonnucleoside reverse transcriptase inhibitor (NNRTI) - 456, 506, 668, 719 Non–AIDS-defining cancers - 160, 620, 632 NPC1L1 - 547 NRTI - 30, 811, 951 NRTI-free AntiretroviralTherapy - 30, 418, 951 NS5A Drug Resistance - 578, 579 NS5A inhibitor - 100 NS5A mutation - 577 Nuclear Import - 209LB Nucleoside reverse transcriptase inhibitor - 437LB Nuke-sparing - 45 –O– OATP1B1/B3 - 460 Obesity - 123, 645, 703 Observational cohort - 708, 721, 778, 951, 962 Older population - 705, 958 Opioid prescriptions - 915, 916 Opportunistic infection - 768 Option B+ - 34, 757, 789, 792, 793, 796, 808 Oral HPV infection - 161 Oraquick - 519

People who inject drugs (PWID) – 27, 533 Peptide - 667 Pericardial fat - 649 Perinatal HIV exposure - 796, 805, 825 Perinatal HIV infection - 823, 825, 830, 834, 836, 838, 851, 856, 857 Periodontitis - 713 Peripheral blood mononuclear cells (PBMCs) - 730 Peripheral neuropathy - 272, 415 Persistence - 80, 86, 229, 340, 402 Persistent replication - 333 Persistent viremic control - 836 Persons who inject drugs (PWID) - 132, 215, 535, 585, 899, 1032 Pharmacodynamics - 104, 430 Pharmacogenetics - 426, 429, 443, 445 Pharmacogenomics - 443 Pharmacokinetics - 98, 99, 104, 425, 426, 428, 431, 438, 441, 448, 453, 454, 455, 456, 457, 458, 574, 775, 818, 882LB, 1120 Pharmacologic measures - 96 Phase I - 876 Phase I/II – 461LB, 816 Phosphate - 651 Phylodynamics – 216, 228 Phylogenetic partioning - 211 Phylogenetics analysis - 210, 214, 217, 221, 223, 225, 232, 379, 400, 490, 541 Platelet function - 662 Platelets – 44LB, 663 PLWH - 434 Pneumococcal vaccine - 328, 768 PNPLA3 variants - 556 Pnumococci - 724 Point of care - 28, 512, 788 Poly-ICLC - 322 Polymerase - 223 Polymorphism - 507 Population based cohort – 116, 218, 917, 954, 982 Population based intervention - 759, 982 Population effectiveness - 1026 Population level ART coverage - 114, 982 Population level impact - 163 Population survey methods - 937 Population viral load - 1026 Phylogenomics - 140 Physical function - 705 Physical performance - 705 PI-containing ARV regimens - 666 Piperaquiine - 101 Plasma - 250 Plasmacytoid dendritic cell - 134

Orphanhood - 845 Osteoporosis - 126

Outbreak - 215, 221, 541, 916 Outcomes - 174, 746, 842, 1030 Oxidative stress - 255 Oxidized LDL - 671, 673 –P– p24 - 137 P2X - 249 P2X7 ATP receptors - 249, 663 p38 MAPK - 467 Partner notification - 978 Partner services - 50, 224 Partner testing - 49, 224 Passive infusion - 309LB, 311LB

Pathogenesis - 24, 243 PCR - 339, 593, 785, 839 Peak HIV viral load - 716 Pediatric AntiretroviralTherapy - 39, 40, 735, 812, 816, 817, 849 Pediatric HIV - 40, 324, 735, 780, 827, 828, 835 PediatricTuberculosis - 735 Pediatrics - 37, 735, 816, 818, 1120

Keyword Index CROI 2016 172